Scientific Sessions 2025  /  Shifting Paradigms in Lipid Management for ASCVD Risk  /  The ODYSSEY of Lipid Lowering: Navigating the Growing Array of Therapeutics for LDL-C Reduction
Logo

American Heart Association

  69
  0

Final ID:

The ODYSSEY of Lipid Lowering: Navigating the Growing Array of Therapeutics for LDL-C Reduction

  • Tokgozoglu, Lale  ( HACETTEPE UNIVERSITY , Ankara , Turkey )
    • Author Disclosures:
    Lale Tokgozoglu: DO have relevant financial relationships ; Consultant:abbott:Active (exists now) ; Speaker:Pfizer:Past (completed) ; Speaker:Sanofi:Active (exists now) ; Consultant:Novonordisk:Active (exists now) ; Consultant:Novartis:Active (exists now) ; Consultant:MSD:Active (exists now) ; Consultant:Menarini:Active (exists now) ; Consultant:Eli Lilly:Active (exists now) ; Consultant:Daiichi Sankyo:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Speaker:Amarin:Past (completed) ; Consultant:Astra:Past (completed) ; Speaker:Amgen:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Shifting Paradigms in Lipid Management for ASCVD Risk

Saturday, 11/08/2025 , 01:30PM - 02:45PM

Main Event

More abstracts on this topic:
CORALreef Lipids Discussant

Lloyd-jones Donald

Addressing Triglycerides for CVD Risk: New Approaches, Different Results?

Orringer Carl

More abstracts from these authors:
How Low and How Fast Should We Go with LDL-Cholesterol?

Ray Kausik, Lloyd-jones Donald, Tokgozoglu Lale

Discussant: Lipoprotein a therapeutics, understanding the pipeline

Tokgozoglu Lale, Goldberg Anne

You have to be authorized to contact abstract author. Please, Login
Not Available